☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
bayer
Bayer Reports Topline Data from P-III (QUANTI) Trials of Gadoquatrane for its Use in MRI
January 13, 2025
Bayer Reports Topline Data from P-III (OASIS 4) Study of Elinzanetant to Treat Vasomotor Symptoms (VMS) Associated with Breast Can...
January 10, 2025
Bayer Reports the US FDA’s sNDA Acceptance of Nubeqa (Darolutamide) to Treat Metastatic Hormone-Sensitive Prostate Cancer
November 22, 2024
Bayer Join Forces with Cytokinetics to Develop and Commercialize Aficamten in Japan
November 19, 2024
Bayer Reports the Regulatory Submission of Nubeqa (Darolutamide) to the EMA for Treating Metastatic Hormone-Sensitive Prostate Can...
October 14, 2024
Bayer Collaborates with MOMA Therapeutics for the Development of a Small Molecule Oncology Program
October 9, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.